Your doctor or pharmacist may already be aware of any possible drug interactions and may be monitoring you for them. Do not start, stop, or change the dosage of any medicine before checking with your doctor or pharmacist first.
Avoid taking MAO inhibitors (e.g., furazolidone, isocarboxazid, linezolid, moclobemide, phenelzine, procarbazine, rasagiline, selegiline, tranylcypromine) within 2 weeks before,...
Read moreWhen it comes to discussions about opioid drugs in the media, they almost always focus on the potential for abuse and addiction. In the... Read more »
A single research report that found risks in one of the medications that we take to control our diabetes would warrant our attention. But... Read more »
Insulin and oral diabetes drugs were in the news recently, as a recent article in the New England Journal of Medicine caught the media's... Read more »
As a physician who has worked in the area of drug safety for many years, I was pleasantly surprised that Consumer Reports, published by... Read more »
Did you see the reports last week that Singulair was going to be investigated by the Food and Drug Administration for reports of a "casual... Read more »
Brand Name: Vyvanse Generic Name: lisdexamfetamine dimesylate Usage: Vyvanse has been approved by the Food and Drug Administration to treat... Read more »
According to the drug manufacturer Shire, the Food and Drug Administration has approved Vyvanse for the treatment of attention-deficit/hyperactivity... Read more »
Health experts caution against eating grapefruit or drinking its juice while taking certain drugs, including those for depression, high blood... Read more »
The U.S. Food and Drug Administration has approved Vyvanse for the treatment of attention-deficit/hyperactivity disorder in adults. Vyvanse is a new... Read more »
A new study by the maker of Vyvanse found that the medication controlled attention- deficit/hyperactivity disorder symptoms in children 6 to 12 years... Read more »